SS Innovations International (NASDAQ: SSII) has reported record second-quarter 2026 revenue of $13.9 million, a 39.4% increase from $10 million in the same period last year. The company attributed this growth to a 30.4% rise in installations of its SSi Mantra surgical robotic system, which reached 30 units in the quarter. Gross profit climbed 20% to $7.1 million, with a gross margin of 50.9%. Despite the revenue surge, the company posted a net loss of $2.7 million, or $0.01 per diluted share, compared with a net loss of $0.3 million a year earlier.
The first half of 2026 saw revenue increase 65.6% to $25 million, while SSi Mantra installations rose 47.4% to 56. As of June 30, SS Innovations held $13.6 million in cash and cash equivalents, with no long-term debt, and a cumulative installed base of 224 SSi Mantra systems across 12 countries. The company also reported 12,272 cumulative procedures using the SSi Mantra, including 175 telesurgeries. Notably, it completed a robotic telesurgery spanning more than 13,600 miles between Colombia and India, demonstrating the system's global reach.
Looking ahead, SS Innovations expects the U.S. Food and Drug Administration to complete its review of the company's 510(k) premarket notification for the SSi Mantra by the end of the first quarter of 2027. Additionally, the company believes it can obtain European Union CE marking certification by the end of 2026. These regulatory milestones are critical for expanding into major markets and could significantly boost adoption.
The company's focus on affordability and accessibility is central to its mission. By offering a cost-effective robotic surgical system, SS Innovations aims to penetrate emerging markets where traditional robotic surgery has been out of reach. The recent telesurgery achievement underscores the potential for remote surgical expertise to bridge geographic gaps, a key value proposition as healthcare systems worldwide seek to expand access to advanced procedures.
However, the increase in net loss from $0.3 million to $2.7 million year-over-year raises questions about cost management and investment in growth. The company's rising revenue and installation numbers suggest strong demand, but achieving profitability remains a challenge. The upcoming regulatory decisions will be pivotal, as approvals could open doors to lucrative markets and potentially accelerate revenue growth.
Investors and industry observers will be watching closely as SS Innovations navigates these milestones. The company's ability to maintain its growth trajectory while managing expenses will be crucial. With a solid cash position and no debt, it has the financial flexibility to support its expansion plans.
For more details, the full press release is available at https://ibn.fm/nTMso. Additional updates can be found in the company's newsroom at https://ibn.fm/SSII.
